Literature DB >> 3779913

Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina.

J C Kaski, F Crea, D Meran, L Rodriguez, L Araujo, S Chierchia, G Davies, A Maseri.   

Abstract

It has been shown in different groups of patients with variant angina that coronary spasm can be reproduced by physiologic maneuvers and pharmacologic agents. It is not known, however, to what extent different stimuli can induce spasm in the same patient. To investigate whether coronary arterial spasm results from specific abnormal agonist-receptor interactions or from a local nonspecific coronary supersensitivity to different stimuli, 28 patients with vasospastic angina were submitted to a series of diverse vasoconstrictive stimuli known to provoke coronary spasm. Ergonovine, hyperventilation, handgrip, cold pressor, and exercise-tests, were carried out in all 28 patients. In the last 15 patients histamine was also administered. Spasm was provoked by ergonovine in 96% of patients, by hyperventilation in 54%, by histamine in 47%, by exercise in 46%, and by the cold pressor and handgrip tests in 11% and 7%, respectively. No significant differences were found in the responses to provocative tests of patients with normal coronary arteries or nonsignificant stenoses and those with significant lesions. In the same individual, spasm was induced by at least two vasoconstrictive stimuli, although with a different mechanism of action, in 82% of patients and spasm was induced by three or more stimuli in 39%. Tests were repeated in at least 23 patients and short-term reproducibility paralleled sensitivity. These results suggest that in patients with variant angina, a local nonspecific supersensitivity rather than an abnormal specific agonist-receptor interaction plays a major role in the genesis of coronary arterial spasm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779913     DOI: 10.1161/01.cir.74.6.1255

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

Review 1.  Heart disease and work.

Authors:  Anne E Price
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Elimination of variable vasomotor tone in studies with repeated quantitative coronary angiography.

Authors:  S Jost; W Rafflenbeul; G H Reil; H J Trappe; D Gulba; H Hecker; U Gerhardt; I Knop
Journal:  Int J Card Imaging       Date:  1990

3.  Relation of basal coronary tone and vasospastic activity in patients with variant angina.

Authors:  Y Ozaki; D Keane; P W Serruys
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

4.  Breathing retraining: a three-year follow-up study of treatment for hyperventilation syndrome and associated functional cardiac symptoms.

Authors:  S DeGuire; R Gevirtz; D Hawkinson; K Dixon
Journal:  Biofeedback Self Regul       Date:  1996-06

5.  Evaluation of high blood pressure and obesity among US coal miners participating in the Enhanced Coal Workers' Health Surveillance Program.

Authors:  Megan Lauren Casey; Kathleen B Fedan; Nicole Edwards; David J Blackley; Cara N Halldin; Anita L Wolfe; Anthony Scott Laney
Journal:  J Am Soc Hypertens       Date:  2017-06-20

Review 6.  [Coronary spasm--a clinically relevant problem?].

Authors:  W Auch-Schwelk
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

Review 7.  Variant Angina and Aborted Sudden Cardiac Death.

Authors:  Amartya Kundu; Aditya Vaze; Partha Sardar; Ahmed Nagy; Wilbert S Aronow; Naomi F Botkin
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

8.  Trazodone overdose-induced Prinzmetal's angina pectoris.

Authors:  Bhesh Raj Karki; Paritosh Prasai; Asim Ruhela; Yub Raj Sedhai
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-09-25

Review 9.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

10.  Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina.

Authors:  K Egashira; T Inou; A Yamada; Y Hirooka; A Takeshita
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.